目标对:用于癌症治疗的临床试验衍生治疗目标组合的单细胞组学资源
Kaicheng Zhou1, Xingxiu Li1, Yuan Yang1
1School of Pharmaceutical Sciences, Shanghai Engineering Research Center of Immunotherapeutics, Fudan University, Shanghai 201203, China.
Journal of molecular biology
|August 21, 2025
概括
开发合理的多目标癌症疗法至关重要. 新的TargetPair数据库系统地列出了临床相关的目标对及其单细胞体质特征,有助于合理的药物设计以改善癌症治疗.
科学领域:
- 癌症学
- 生物信息学
- 计算生物学
背景情况:
- 瘤微环境 (TME) 在癌症治疗中提出了重大挑战.
- 多重定位策略显示出临床前景,但通常依赖于经验方法.
- 针对多个目标治疗的目标对 (TP) 的合理设计是优先考虑的.
研究的目的:
- 解决关于临床相关癌症TP及其单细胞特征的综合数据的缺乏.
- 建立一个手动注释的TP数据库与相关的OMIC特征.
- 促进多目标癌症治疗的合理设计.
主要方法:
- 药物组合和多向药物的手动注释,具有评估的抗瘤功效.
- 对TP的单细胞体质特征的计算,包括共表达,分布和细胞分数.
- 来自55个出版物的单细胞RNA测序 (scRNA-seq) 数据集.
主要成果:
- 该数据库包含60个已批准的,1580个临床阶段的和7424个实验阶段的TP.
- 从3470个临床试验和1396个出版物中进行了说明.
- 在13种细胞类型,16种癌症类型和588名患者中,从3,022,556个单细胞中获得了奥米克特征.
结论:
- 目标对数据库为了解单个细胞水平的TP提供了宝贵的资源.
- 这种资源可以帮助合理设计新的多向癌症疗法.
- 为了研究目的,该数据库可以在网上免费访问.
更多相关视频
相关概念视频
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Clinical Trials
8.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.1K


